Phytochemical investigation and anti-inflammatory potential of Atriplex leucoclada Boiss

• Published in: BMC complementary and alternative medicine Vol. 23; no. 1; p. 464
• Main Authors: Ahmed, Hayam S, Mohamed, Enas I A, Amin, Elham, Moawad, Abeer S, Sadek Abdel-Bakky, Mohamed, Almahmoud, Suliman A, Afifi, Naglaa
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 16-12-2023; BioMed Central; BMC
• Subjects: A. leucoclada; Affinity; Analysis; Anti-inflammatory; Anti-inflammatory agents; Anti-Inflammatory Agents - chemistry; Anti-Inflammatory Agents - pharmacology; Atriplex; Atriplex - metabolism; Chromatography; COX; Cyclooxygenase 2 - metabolism; Deserts; Ecdysone; Enzymes; Force and energy; Fractions; GC–MS; Guanylate cyclase; Health aspects; Hexanes; Ibuprofen; In vitro methods and tests; Inflammation; Investigations; Mass spectrometry; Metabolites; Methanol; Molecular docking; Molecular Docking Simulation; n-Hexane; NMR; Nonsteroidal anti-inflammatory drugs; Nuclear magnetic resonance; Pharmacology; Phytochemicals; Phytochemicals - chemistry; Phytochemicals - pharmacology; Plant Extracts - chemistry; Plant species; Saudi Arabia; Scientific imaging; Software; Steroids; Saudi Arabia; United States > US; Switzerland; Germany; GC–MS; NMR; A. leucoclada; Molecular docking simulation; Anti-inflammatory; COX
• ISSN: 2662-7671; 2662-7671; 1472-6882
• DOI: 10.1186/s12906-023-04281-5

The plant kingdom has long been considered a valuable source for therapeutic agents, however, some plant species still untapped and need to be phytochemically and biologically explored. Although several Atriplex species have been investigated in depth, A. leucoclada, a halophytic plant native to Saudi Arabian desert, remains to be explored for its phytochemical content and biological potentials. Herein, the current study investigated the metabolic content and the anti-inflammatory potential of A. leucoclada.
Powdered aerial parts of the plant were defatted with n-hexane then the defatted powder was extracted with 80% methanol. n-Hexane extract (ATH) was analyzed using GC-MS, while the defatted extract (ATD) was subjected to different chromatographic methods to isolate the major phytoconstituents. The structures of the purified compounds were elucidated using different spectroscopic methods including advanced NMR techniques. Anti-inflammatory activity of both extracts against COX-1 and COX-2 enzymes were examined in vitro. Molecular docking of the identified compounds into the active sites of COX-1 and COX-2 enzymes was conducted using pdb entries 6Y3C and 5IKV, respectively.
Phytochemical investigation of ATD extract led to purification and identification of nine compounds. Interestingly, all the compounds, except for 20-hydroxy ecdysone (1), are reported for the first time from A. leucoclada, also luteolin (6) and pallidol (8) are isolated for the first time from genus Atriplex. Inhibitory activity of ATD and ATH extracts against COX-1 and COX-2 enzymes revealed concentration dependent activity of both fractions with IC
41.22, 14.40 μg/ml for ATD and 16.74 and 5.96 μg/ml for ATH against COX-1 and COX-2, respectively. Both extracts displayed selectivity indices of 2.86 and 2.80, respectively as compared to 2.56 for Ibuprofen indicating a promising selectivity towards COX-2. Molecular docking study supported in vitro testing results, where purified metabolites showed binding affinity scores ranged from -9 to -6.4 and -8.5 to -6.6 kcal/mol for COX-1 and 2, respectively, in addition the binding energies of GC-MS detected compounds ranged from -8.9 to -5.5 and -8.3 to -5.1 kcal/mol for COX-1 and 2, respectively as compared to Ibuprofen (-6.9 and -7.5 kcal/mol, respectively), indicating high binding affinities of most of the compounds. Analysis of the binding orientations revealed variable binding patterns depending on the nature of the compounds. Our study suggested A. leucoclada as a generous source for anti-inflammatory agents.